Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Type I IFN Level and Disease Activity in SLE Patients

NCT05446428 is registered in ClinicalTrials.gov with V.A. Nasonova Research Institute of Rheumatology, Moscow as lead sponsor.

NCT NCT05446428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05446428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Type I IFN Level and Disease Activity in SLE Patients
Lead sponsor
V.A. Nasonova Research Institute of Rheumatology, Moscow
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2022
Completion date
July 31, 2024
Enrollment
70 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

elevated level of ifn type i in sle patients